Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

US Patent 11278571 · Granted Mar 22, 2022

Estimated economic value: $1,684,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for the characterization of peptide:MHC binding polypeptides2025
Method and device for providing a storage capacity reserve in a traction battery2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
MAGEB2 binding constructs2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use immunotherapy against different types of cance2025
Peptides displayed by HLA for use immunotherapy against different types of cance2025
Antigen binding proteins specifically binding MAGE-A2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Peptides displayed by HLA for use in immunotherapy against different types of ca2025
Immunotherapy with B*08 restricted peptides and combination of peptides against 2025
Immunotherapy with B*07 restricted peptides and combination of peptides against 2025